Radiant Pharmaceuticals Limited is proud to take part in CPHI 2025 in Frankfurt, the world’s largest and most influential pharmaceutical exhibition, bringing together over 2,500 companies and 45,000 professionals from across the globe.
This year, Radiant highlights its expanding international footprint by presenting its NSF USA–certified contract manufacturing (CMO) services for OTC products—reinforcing the company’s commitment to uncompromising quality, safety, and compliance.
Following Radiant’s acquisition of Nevian Lifescience PLC, the group now brings a unified portfolio of global manufacturing capabilities under one vision. Nevian’s EU-GMP and ANVISA-certified facilities strengthen Radiant’s capacity to serve partners seeking world-class pharmaceutical production.
Radiant remains dedicated to advancing meaningful global collaborations by offering reliable, high-quality, and innovative manufacturing solutions. Through its presence at CPHI 2025, the company continues to build pathways for long-term partnerships and drive excellence for the global healthcare community.